Cancer Vaccines



May 30, 2023

  • Share
  • Vaccines were originally developed as a prophylactic agent, administered to healthy individuals to induce long-term immunity against a pathogen and to prevent the outbreak of viral diseases. Therapeutic vaccines aim at inducing strong antigen-specific T cell responses. In contrast to prophylactic vaccines, they are used in patients who already have a growing, established tumor. In the field of cancer immunotherapy, prophylactic vaccination only applies to the few virally induced malignancies, such as the vaccine against hepatitis B virus that can cause liver cancer, or the nowadays widespread human papilloma virus (HPV) vaccination of teenagers, which aims to prevent genital cancers induced by high-risk HPV strains.

    Drug DiscoveryImmunology

    Keep up to date with all your favourite videos and channels.

    Get personalised notifications on new releases and channel content by subscribing to the LabTube eNewsletter.